Mingchao Kang

Mingchao Kang

Company: Ambrx

Job title: Project Leader


Dr. Kang received his Ph.D. in Chemistry at the Scripps Research Institute in the laboratory of Dr. Peter G. Schultz, who is the co-founder of Ambrx, Inc. Then he was trained as a postdoc in the Inder Verma group at the Salk Institute. He is currently leading multiple oncology projects at Ambrx by harnessing the power of introducing nonnative amino acids through an expanded genetic code to generate novel biotherapeutics.  

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.